Sessions

*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP05-140-21-Using patient pathway analysis in Rwanda: methods, problems and the importance of data and sensitivity analysisThis patient pathway analysis was done to inform the alignment between the availability of tuberculosis diagnostic and treatment services at facilities in Rwanda and care seeking behaviour towards these facilities.
Puck Pelzer

EP05-141-21-Improving surveillance data quality in Nikshay: introduction of machine assisted deduplicationAll healthcare providers in India, including laboratories and chemists, are required to notify cases of tuberculosis (TB) in Nikshay - the national TB surveillance system - increasing the risk of duplicate notifications. To prevent this, a machine-assisted deduplication mechanism has been developed, providing an approximate 25% positive predictive value.
Jyoti Jaju

EP05-142-21-The paradox of free TB care in private-for-profit private care facilitiesThe provision of a public health intervention within private-for-profit facilities is morally appealing but can be faced with the challenge of overhead costs. In the implementation of PPM-DOTs models, businesses' operational costs must be considered and incentive packages tailored to mitigate these costs as part of tuberculosis care service for sustainability.
Dziedzorm Awalime

EP05-143-21-Pillar Two of the End TB Strategy: impact of bold policies and supportive systems on programme implementation in IndiaArticle documents the improvement in coverage of nutritional support scheme as a result of intensive monitoring of the same, reiterating the need for adequate political commitment with adequate resources for a tuberculosis free world
Deepak Balasubramanian

EP05-144-21-Comparison and analysis of different mode of administration for TB treatment in Papua New GuineaThis study compares treatment outcomes in tuberculosis (TB) patients using three modes of administration (MOA), including directly observed treatment (DOT) by treatment supporters, self-administrated treatment (SAT), and family model (FM). We also assessed adherence in a small cohort of multidrug-resistant TB patients with SAT versus FM.
Rakhat Akmatova

EP05-145-21-Patient-centred TB treatment support tools: a mixed method, randomised controlled pilot study exploring initial efficacy and refinement needsWe present the initial assessment of the tuberculosis (TB) treatment support tools (TB-TSTs) intervention. TB-TSTs links a patient-centred mobile application, a paper-based drug metabolite urine test and interactive communication with a treatment supporter. The study was conducted within a public respiratory specialised reference hospital in Argentina.
Sarah Iribarren

EP05-146-21-Evaluation of the accuracy of 99DOTS digital adherence technology for TB in Metro Manila, PhilippinesThe accuracy of 99DOTS, a mobile phone digital adherence tool enabling remote monitoring of tuberculosis (TB) drug intake, was evaluated in a Metro Manila pilot. Results from 103 participants showed the following findings: PPV=97.9%, NPV=0.0% and sensitivity=94.1%. 99DOTS adherence is corroborated by the IsoScreen used to represent true adherence status.
Jason Alacapa

EP05-147-21-Fully oral rifampicin-resistant TB treatment regimens: progress in removing injectable agents from high TB burden country policiesWhile progress has been made in high tuberculosis (TB) burden countries towards policy guidance for shorter and longer all-oral rifampicin- resistant tuberculosis (RR-TB) regimens recommended by the World Health Organization, results from the #StepUpforTB 2020 study shows slow changes in phasing out injectable agent use for routine RR-TB treatment.  
Pilar Ustero

EP05-148-21-Patient-centred care for drug-resistant TB: responding to diverse clinical and social circumstancesSouth African healthcare remains poorly responsive to the socio-economic and psychological needs of patients. Patients experience complex medical and social challenges, which belie a one-size-fits-all model of care. Service delivery needs to be differentiated in order to better address specific needs and vulnerabilities of individual patients.
Leila Mitrani

EP05-149-21-Perspectives on access to TB health services in Shigatse, Tibet, ChinaA qualitative study exploring the experiences and perspectives of access to tuberculosis (TB) care among people living with TB in Shigatse, Tibet China. Ten semi-structured interviews were conducted with Tibetan interpretation as well as analysis using an access-to-care framework to conceptualise determinants of access to TB care.
Victoria Haldane

EP05-150-21-Beyond free medical care: why TB patients seeking treatment in national TB programme facilities still face catastrophic expenses in the Philippines?This study determines the drivers of costs faced by tuberculosis (TB) patients seeking treatment in government facilities. Using a cross-sectional survey of 1,880 TB patients, it provides an estimate of the proportion of TB-affected families facing catastrophic cost in the Philippines.
Rosa Mia Arao

EP05-151-21-Short- and long-term outcomes of video observed TB treatment among patients in Chisinau, the Republic of MoldovaVideo Observed Treatment (VOT) in addition to Directly Observed Treatment Strategy (DOT) was piloted in the Republic of Moldova. A study involved 83 tuberculosis patients on VOT and 86 on DOT. VOT reduced required time and travel costs for treatment while maintaining high levels of adherence and favourable treatment results.
Svetlana Doltu

*Please scroll down for more information*


11:00 - 11:05: Introduction


11:05 - 11:13: OA-04-522-21-“You have to adjust your whole life.” Interconnected, dynamic influences on adherence to treatment for TB among adults in three UK cities Non-adherence to tuberculosis (TB) treatment has significant implications for individual patients and for efforts to end TB. A better understanding of how factors affecting the non/adherence intersect can guide development of patient-centred, cost-effective measures to improve treatment taking. We report on in-depth interviews with individuals on TB treatment in the United Kingdom.

Aaron S Karat

11:13 - 11:21: OA-04-523-21-Doubling TB preventive treatment enrolment rates among people living with HIV in Ukraine Under the United States Agency for International Development funded Challenge TB (CTB) mechanism, PATH used a data-driven, evidence-grounded advocacy approach to shift the management of tuberculosis (TB) preventive treatment (TPT) services for people living with HIV (PLHIV), in Donetsk Oblast, from TB doctors to HIV specialists. This shift led to a doubling of PLHIV initiated on TPT.

Olga Pavlova

11:21 - 11:29: OA-04-524-21-Providing incentives and enablers to support people suffering with TB completing their treatment in Belgium: a successful approach In Belgium, tuberculosis (TB) treatment completion remains challenging, especially among the most vulnerable groups, such as the homeless or people living in irregular situations. Since 2015, a joint project between the Belgium TB Programme and non-governmental organisation, has looked to provide incentives and enablers, including shelters, to improve treatment outcomes.

Lilas Weber

11:29 - 11:37: OA-04-525-21-Video observed treatment for TB patients in Belarus In Belarus, with the Global Fund’s support, a pilot video-observed treatment (VOT) project was expanded across the country in October 2016. VOT for tuberculosis patients in Belarus, used at programmatic level, demonstrates high levels of patient acceptability and excellent treatment outcomes.

Alena Skrahina

11:37 - 11:45: OA-04-526-21-ART prescription by TB doctors in Odeska oblast, Ukraine: successful model of integration of services for patients with TB-HIV co-infection In Ukraine, only HIV specialists are permitted to prescribe antiretroviral treatment (ART), which leads to delayed initiation and low ART coverage among tuberculosis (TB) patients. The United States Agency for International Development funds the Challenge TB Project and its support has enabled TB doctors to prescribe ART. This resulted in a significant increase of ART coverage and reduction of ART initiation delays.

Olga Pavlova

11:45 - 11:53: OA-04-527-21-Results of pilot of integrated diagnosis of TB and hepatitis C among HIV-positive incarcerated individuals using GeneXpert in Dnipropetrovska oblast of Ukraine Usage of GeneXpert opportunities as an integrated patient-oriented approach for TB and hepatitis C virus diagnosis, and HIV viral load determination, among detainees and prisoners in Dnipro Penal Institution №4, in Ukraine, greatly reduces turnaround times and improves efficiencies while also increasing access to services for prisoners and detainees.

Svitlana Leontieva

11:53 - 12:01: OA-04-528-21-COVID-19-TB and multidrug-resistant TB co-infection in Belarus Belarus, a high burden multidrug-resistant TB country, had a total of 22,973 confirmed COVID-19 cases on May 10th. Measures to monitor COVID-19-TB patients prospectively, in the countrywide cohort, were developed. Our data will help create a global database for the subsequent generation of evidence-based recommendations to combat both infections. 

Alena Skrahina

12:01 - 12:20: Q&A

*Please scroll down for more information*


15:00 - 15:05: Introduction


15:05 - 15:13: OA-06-536-21-Community health workers augment the cascade of TB detection to care in urban slums of two metro cities in India The Tuberculosis Health Action Learning Initiative (THALI) recruited community health workers, in urban slums in two metro cities in India, to augment tuberculosis (TB) detection to care cascade. Their performance and TB treatment outcomes improve over time. It will be important to examine the cost per-TB case detected and successfully treated.

RAJARAM Potty

15:13 - 15:21: OA-06-537-21-Improving isoniazid preventive therapy coverage among children aged 0-14 years living with HIV through designating special clinic days: case of Kapelebyong Health Centre IV Isoniazid preventive therapy demonstrated efficacy of over 60% in preventing active tuberculosis (TB) among people with latent TB infection. However, uptake is low. People of all ages living with HIV, who attend the clinic at the same time, limits opportunities for special care, emphasising the need for age-sensitive HIV clinics to address unique challenges. 

Pius Ongareno

15:21 - 15:29: OA-06-538-21-Using market-based e-pharmacies for delivering free TB drugs to patients treated in the private sector: lessons learned from a pilot in Madhya Pradesh, India This innovative demonstration model of engaging e-pharmacy companies for door step delivery of national TB elimination programme-supplied anti-TB drugs, diagnostic services and treatment adherence support, to patients treated in the private sector.

Varsha Rai

15:29 - 15:37: OA-06-539-21-The potential of mHealth to improve TB awareness and case detection in Tanzania Provide support to the Tanzania National Tuberculosis and Leprosy Program (NTLP)  through the implementation of mHealth technologies to increase case detection and enhance TB knowledge among the general public in Tanzania.

Eunice Moturi

15:37 - 15:45: OA-06-540-21-Identifying subpopulations at high-risk for severe adherence challenges in the treatment of multi- and extensively drug-resistant TB and HIV In generalised epidemics of drug-resistant tuberculosis (DR-TB) and HIV, identifying high-risk subpopulations is critically important to improve treatment outcomes and prevent amplification of resistance. We hypothesised that an electronic dose-monitoring device could empirically identify adherence-challenged patients and that a mixed methods approach would characterise treatment challenges.

Jennifer Zelnick

15:45 - 16:20: Q&A

*Please scroll down for more information*


16:30 - 16:35: Introduction


16:35 - 16:43: OA-09-550-21-Using the patient pathway analysis method to align care-seeking and service delivery in development of a person-centred, national strategic plan The patient pathway analysis uses data to identify a mismatch between tuberculosis (TB) healthcare-seeking and service delivery. Fifty eight percent of the population initially sought care in private facilities, of which only 2% were equipped with diagnostic capacity for TB, emphasising the need to engage private sector facilities in TB control.

Moses Arinaitwe

16:43 - 16:51: OA-09-551-21-A 360 degree view of TB-related stigma in Uganda: findings from a mixed methods study involving perceptions from patients, providers and communities Stigma is a key driver that hinders tuberculosis (TB) control programmes by negatively affecting delay in care-seeking and treatment adherence. A mixed methods assessment was conducted to understand perceptions and knowledge of TB-related stigma among TB providers, patients and community members, to inform  TB programme strengthening efforts in Uganda.

Nikki Davis

16:51 - 16:59: OA-09-552-21-Support for integrating TB preventive treatment into community antiretroviral refill groups among people on antiretroviral treatment in Zimbabwe Zimbabwe's 2018 tuberculosis (TB) incidence - 210/100,000 - is among the highest globally. However, only 11% of people living with HIV (PLHIV) and newly enrolled in care, were on TB preventive treatment (TPT) in 2017. Community antiretroviral refill groups can be an efficient way to scale-up TPT in PLHIV in Zimbabwe. 

Jennifer M. Zech

16:59 - 17:07: OA-09-553-21-Integrating mental health services into TB care: Gujarat, India Mental health interventions to treat depression among tuberculosis (TB) patients were integrated into routine TB workflows. Healthcare workers, trained in psychotherapeutic counselling, screened for depression symptoms, administered 4-6 sessions with patients and measured reduction in depression symptoms with each session.

Sirisha Papineni

17:07 - 17:15: OA-09-554-21-Journey patterns and models of care observed in patients receiving drug-resistant TB treatment in South Africa This analysis uses spatio-temporal mapping of patient care journeys in South Africa to describe diverse patterns - ranging from highly centralised to highly decentralised - and uses these to provide structure to illustrate existing models of care. Five dominant geospatial movement patterns of patient journeys, and the associated care models, are described. 

Lindy Dickson-Hall

17:15 - 17:23: OA-09-555-21-Implementation of a supportive care package to strengthen drug-resistant TB patients' adherence to treatment in Xi'an, China Implementation of a comprehensive, supportive care package to strengthen treatment enrollment, retention and treatment adherence to among drug-resistant tuberculosis patients managed by Xi’an City Chest Hospital, western China

Ali Zhao

17:23 - 17:50: Q&A

*Please scroll down for more information*
Addressing comorbidities is a core component of patient-centred care within the End TB Strategy. Diabetes is associated with a two to three-fold risk of TB. TB can temporarily cause impaired glucose tolerance and a person with TB is significantly more at risk of dying or relapsing if they also have diabetes - all important reasons for collaborative action as outlined in The Union and World Health Organization 2011 Collaborative Framework for Care and Control of TB and Diabetes. This symposium will present evidence on the global uptake of collaborative action on TB and diabetes and share barriers, enablers, plans and opportunities for scale-up.

16:30 - 16:35: Introduction

16:35 - 16:45: Global status on uptake of the Union/World Health Organization Collaborative Framework for the Management of Tuberculosis and DiabetesThe Union/World Health Organization (WHO) Collaborative Framework for the Management of Tuberculosis and Diabetes was published in 2011. While we have seen impressive scale-up of collaborative action on HIV-associated tuberculosis (TB) globally during this period, uptake and scale-up of collaborative TB and diabetes activities appears to have been limited and difficult to gauge. This presentation will introduce the symposium and provide an overview of findings from a policy review conducted by WHO to assess uptake by high burden TB countries of the collaborative framework for the management of tuberculosis and diabetes and outline plans to promote further scale-up.
Annabel Baddeley

16:45 - 16:55: Addressing comorbidities as part of high impact TB interventions in Global Fund funding requests and grantsThe presentation will share opportunities from the Global Fund to address comorbidity as one of the high impact interventions – this includes the Global Fund strategy and policy on supporting comorbidity, integrated services and promotion of innovations. Further opportunities are available through catalytic funding to support innovative interventions to find missing people with tuberculosis/drug-resistant tuberculosis (TB), including among high risk groups such as people with diabetes. Additional resources to address TB and comorbidity could be leveraged through existing country grants (savings and reprogramming), portfolio optimisation and new grants.
Mohammed Yassin

16:55 - 17:05: Challenges, enablers and plans for scaling up integrated action on TB and diabetes: lessons from PakistanThe dual burden of diabetes and tuberculosis (TB) is a serious and growing challenge for the poorly resourced health system of Pakistan, which ranks 5th among the high TB burden countries. The number of diabetics are estimated to rise to 13.9 million by 2020 in Pakistan, increasing country ranking to 4th in the world. This presentation will give an overview of studies that have been conducted to pilot bi-directional screening for diabetes in TB clinics and for TB in diabetes clinics. It will also discuss the challenges and barriers to integration at all levels of the health system and how the country plans to ensure integrated and structured bi-directional screening, referral, case management and follow-up is scaled up from 2020-2023.
Aurangzaib Quadir Baloch

17:05 - 17:15: Experience of initiating TB preventive treatment among people with diabetes in BrazilThe national tuberculosis (TB) programme of Brazil has recently been introducing a policy on TB prevention among people with diabetes. This presentation will give an overview of the epidemiology of TB and diabetes in Brazil, common aspects and areas for synergy between the two programmes, Brazil’s experience of introducing programmatic management of latent TB infection as well as preliminary results of TB preventive treatment in people affected by diabetes.
Denise Arakaki-Sanchez

17:15 - 17:25: Introducing diabetes into TB-HIV collaboration: opportunities and plans for addressing multimorbidity in ZimbabweZimbabwe is one of the high tuberculosis (TB) burden countries with more than half of people with TB co-infected with HIV. In 2017, the prevalence of diabetes among adults in Zimbabwe is estimated to be 1.8% and over 75.0% of those with diabetes had never been diagnosed. This presentation will give an overview of the epidemiological background and the steps taken to assess feasibility of implementation and to scale-up collaborative action on TB and diabetes in Zimbabwe.  It will further discuss the challenges, enablers, opportunities and plans for national scale-up of integrated TB, diabetes and HIV care.
Charles Sandy

17:25 - 17:50: Q&A session

*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP22-307-23-Implementation of TB preventive treatment in South Africa: the urgent need to address gapsTuberculosis (TB) and HIV are major global public health concerns. Providing TB preventive treatment (TPT) to people at risk of progressing to TB disease decreases TB transmission and TB-related mortality. We compared TPT initiations and completions between two fiscal years to identify programme gaps.
Katlego Motlhaoleng

EP22-308-23-TB preventive treatment preferences among children in Eswatini: a mixed methods studyUnderstanding preferences regarding tuberculosis preventive treatment (TPT) regimens’ characteristics and service delivery models, is key to efforts to improve TPT initiation and completion. We report on results from a mixed methods study, including a discrete choice experiment and qualitative interviews among children in Eswatini, an African country with high TB burden.
Yael Hirsch-Moverman

EP22-309-23-Low completion rate of once-weekly rifapentine plus isoniazid regimen among elderly populationWith the advanced preventive therapy as a cornerstone of End TB, a better regimen which is easier for elderly contacts to complete is crucial, since interruption of preventive therapy among elderly populations is not improved by providing 3HP.
Pei-Chun Chan

EP22-311-23-Risk based patient-centred strategies for TB treatment. Inference from a prospective cohort studyTo optimise strategies for prevention and management of tuberculosis, (TB) we need to adapt available resources and implement patient-centred approaches. Implementing different treatment strategies considering a patient baseline risk, organisation of healthcare delivery and interventions for social inclusion, will probably result in better TB outcomes in resource-constrained systems.
Fernando Rubinstein

EP22-312-23-Perspectives of multidrug-resistant TB patients on the use of treatment supporters: experience from Lagos, NigeriaA qualitative study to explore the patient perspective when using treatment supporters in multidrug-resistant tuberculosis (MDR-TB) care. From the patients’ perspectives, they found it very supportive and family members were preferred as treatment supporters because of the closeness, and the ability to support, patients emotionally in the course of treatment.
Oluremilekun Kusimo

EP22-313-23-Improving treatment adherence with technology and patient-centred care in MoroccoA comprehensive tuberculosis (TB) management programme using mHealth and patient-centred management was implemented to reduce the rate of patients lost to follow-up in Morocco. Patients who enrolled in the programme showed an improved treatment success rate and the new TB management programme could be applicable in other countries under similar circumstances.
Narae Moon

EP22-314-23-The effect of digital dosing monitoring on the adherence of patients treated for TB in Viet NamNon-adherence is an important risk factor for relapse among patients with tuberculosis (TB). This study evaluated the effect of digital adherence support, using a Medication Event Reminder Monitor (MERM), for outpatients treated for newly diagnosed, smear-positive pulmonary TB in Viet Nam.
Thu-Anh Nguyen

EP22-315-23-Impact of health-related quality of life on treatment adherence during treatment for pulmonary TBThis abstract describes how health-related quality of life, while receiving drug-sensitive tuberculosis (TB) treatment, impacts on treatment adherence. It is part of an ongoing observational cohort study among adult patients receiving treatment for TB through national TB programmes in The Gambia, Mozambique, South Africa and Tanzania. 
Tembeka Sineke

EP22-316-23-Evaluation of the integrated multidrug-resistant and rifampin-resistant TB patient management approach in Wuhan Jinyintan Hospital, Hubei Province, ChinaA retrospective analysis of year-one patient data of three intervention cohorts to evaluate the integrated multidrug-resistant tuberculosis and rifampin-resistant tuberculosis patient management approach implemented in Wuhan Jinyintan Hospital, Hubei Province, China
Qi Nie

EP22-317-23-Peer empowerment to strengthen treatment adherence among multidrug-resistant TB patients: field experience in Shaanxi Province, ChinaPeer empowerment was introduced by Xi'an Chest Hospital's medical staff to provide support to local multidrug-resistant tuberculosis patients in order to enhance treatment adherence. This is the field experience in Xi'an, Shaanxi Province in Western China.
Hui Luo

EP22-318-23-Diverse patterns of TB medication adherence seen via directly observed therapy in an observational cohortWe analysed directly observed therapy (DOT) data from a prospective drug-susceptible tuberculosis (TB) cohort in Worcester, South Africa. Participants were more likely to miss doses during the therapy continuation than the initiation phase. Among those who were 60-90% adherent, there was significant variation in the TB treatment adherence patterns.
Tara C Bouton

*Please scroll down for more information*
All E-posters are accessible via the "E-posters" section of the conference platform until 30 November.

EP26-344-23-Feasibility of appreciative inquiry to co-create an evaluation framework for TB and HIV Extension for Community Healthcare Outcomes (ECHO) implementation in India and TanzaniaEvaluating training and education initiatives such as Project ECHO (Extension for Community Healthcare Outcomes) is essential to understand impact. We describe the feasibility of an appreciative inquiry approach that engages stakeholders in creating an evaluation framework to assess TB and HIV ECHO implementation in India and Tanzania.
Smita Ghosh

EP26-345-23-Creating TB awareness through active involvement of learners in secondary schools: A case of Amref Health AfricaDocumentation of strategies used to create tuberculosis (TB) awareness in public secondary schools in five high burdened counties in Kenya. The school fraternity was equipped with TB education and students were able to create unique TB-related performing arts that were presented during World TB day, reaching various community members.
Christine Mwamsidu

EP26-346-23-Integration of family-focused education and counselling in Daru TB preventive therapy programmeIntegration of family-focused education and counselling into the preventive therapy programme in Daru has led to improved understanding of latent tuberculosis by families of children on treatment. It has also contributed to improvements in treatment adherence and rates of treatment completion.  
Allan Kuma

EP26-347-23-Experience describing co-creation of an assessment framework for implementation of a virtual learning platform: TB Extension for Community Healthcare Outcomes implementation in IndiaProject ECHO (Extension for Community Healthcare Outcomes) leverages virtual video conferencing technology to build capacity, disseminate knowledge and promote mentorship through case-based learning. An appreciative inquiry approach was utilised to engage stakeholders and co-create a comprehensive assessment framework and data collection tools in order to assess TB ECHO implementation in India.
Smita Ghosh

EP26-348-23-Engaging first line care providers for screening and referral of presumptive TB patients in Nigeria: results of a targeted approachCommunity pharmacists and patient medicine vendors play a key role in expanding patient-centred approaches to tuberculosis (TB) care. Stakeholders for TB control need to imbibe the right strategy to engage these important first line care providers for effective and standardised implementation in order to significantly contribute to TB case finding.
Chidubem Ogbudebe

EP26-349-23-Unprepared and unprotected: graduating medical students’ knowledge, attitudes and practices regarding drug-resistant TB in Cape Town, South AfricaSouth Africa has a high burden of drug-resistant TB, which is managed extensively by junior clinicians at the primary care level. In this cross-sectional study, we assessed the knowledge, attitudes and practices of graduating medical students at the University of Cape Town, South Africa.
Johnathan Watts

EP26-350-23-Can patient navigators help potential TB patients navigate the diagnostic and treatment pathway?People brave a variety of social, structural and health system barriers to seek healthcare in fragmented and complex health systems. Patients navigators can change this. We evaluate navigators’ utility in enabling person-centred care in both public and private sector tuberculosis programmes in India.
Miranda Brouwer

EP26-351-23-A new 'normal' for health service provider capacity building in response to the COVID-19 pandemic in the PhilippinesWith travel restrictions and physical distancing to contain COVID-19, a new way of capacity building for healthcare providers is needed. We share the results of synchronous, web-enabled, class-based training on national tuberculosis guidelines, which was conducted for a pool of trainers in place of face-to-face training in the Philippines.
Ruth Orillaza-Chi

EP26-352-23-Study of participant satisfaction with directly observed therapy and TB programme staff members' interpersonal skills, patient education and patient-centred communicationsWe conducted a randomised crossover trial comparing in-person, directly observed therapy (ipDOT) with electronic DOT (eDOT) for tuberculosis (TB) treatment in NYC. We report participants’ satisfaction with both DOT methods as well as responses to questions focusing on TB programme staff members' interpersonal skills, provision of patient education and patient-centred communications.
Marco M. Salerno

EP26-353-23-Knowledge, attitudes and current practices and roles of pharmacy professionals concerning TB treatment in IndonesiaWith 52% of initial care-seeking by tuberculosis (TB) patients happening in pharmacies and drug stores in Indonesia, pharmacies can be an effective channel to direct presumptive TB patients to health facilities for diagnosis and care. This is a digital, cross-sectional survey investigating pharmacy professionals’ knowledge, attitudes and practices concerning TB.
Vania Gones

*Please scroll down for more information*
Globally, definitions and metrics of high quality tuberculosis (TB) care are informed primarily by clinical perspectives. These definitions exclude what patients define as high quality care and are often at odds with patients’ socioeconomic realities. This affects both their experience of care and their ability to battle TB. Hence, it is critical that person-centred care is defined by patients and communities themselves. Departing from medicalised models of care, this session combines expert and patient perspectives to create an inclusive patient-led conversation around person-centred care, emphasising the importance of patient perspectives in ensuring high quality of care in TB.

11:00 - 11:05: Introduction

11:05 - 11:15: Why we need a patient-led and person-centric solution in TBThis presentation talks about the need for patient-led models of person-centric care. It examines the relevance of this approach for large populations at risk globally, especially those most vulnerable, and how to best cater to them, based on examples and case studies. It examines this by looking at current challenges that need to be addressed through such models in global approaches to stemming the tuberculosis epidemic.
Madhukar Pai

11:15 - 11:25: A patient's definitions of care: challenges and opportunitiesThis presentation draws on the presenter’s experience as a tuberculosis (TB) patient. Using lived experience identifies the systemic, treatment, economic and personal challenges that patients face in accessing appropriate care. In doing so, it seeks to identify the key challenges faced by patients and communities at risk, and how understanding these perspectives gives opportunities to define high quality care that the health system ought to provide to patients.
Ashna Ashesh

11:25 - 11:35: Community and patient participation in defining health needs and health policy: what does TB need?This presentation illustrates significant approaches to participative approaches to defining health needs and using it to inform policy. It compares participation and community-led models of communities' making and defines quality of care across diseases and in different countries. In doing so it seeks to draw lessons for enhancing community and patient participation in identifying needs and the framing of policies and interventions for defining tuberculosis care.
Amrita Daftary

11:35 - 11:45: Patients defining care as consumers: what we can learn from other diseasesDrawing from the presenter’s experience as a tuberculosis (TB) survivor and a person living with HIV, this presentation will do a comparative analysis of the experience of patients defining care in both diseases. It will examine how this has impacted the patient experience of receiving care and the lessons that can be drawn to make TB care person-centric. In particular it will focus on issues of how care can become more person–centred, address issues of patient support, mental health and stigma.
Sunil Gupta

11:45 - 11:55: A model of care from a survivor’s perspective: key elementsThis presentation seeks to present some fundamental aspects that a patient and community-led model of person-centred care must include. The presenter draws on presented challenges and opportunities and his experiences as a tuberculosis survivor, and sketches out the key elements that community and patient-led models of care must include.  
Saurabh Rane

11:55 - 12:20: Q&A session

*Please scroll down for more information*


12:30 - 12:35: Introduction


12:35 - 12:43: OA-26-661-23-The use of geographic information systems technology and self-reported data to characterise congregate settings with high potential risk for TB transmission in an urban African area The use of geographic information systems technology, coupled with data provided by tuberculosis (TB) cases, can inform local public health interventions which target congregate settings with a high potential risk for TB transmission. In a retrospective cohort study conducted in an urban area in Uganda, we characterised and mapped these high-risk indoor congregate settings.

Maria Eugenia Castellanos Reynosa

12:43 - 12:51: OA-26-662-23-Bundling innovations for public-private mix: experience of artificial intelligence-augmented chest X-Ray screening and TrueLab for diagnosis To increase tuberculosis (TB) case detection in Nagpur slums, a public- private mix intervention was implemented with a novel Qure.ai software installed in private sector chest X-ray labs. Presumptive TB patients with abnormal chest X-ray results were confirmed microbiologically using TrueLab tests in a public sector hospital and linked for public sector treatment.

Shibu Vijayan

12:51 - 12:59: OA-26-663-23-Reducing turnaround time by transitioning from paper-based to digital signature certificate-based approval of direct benefit transfers under National Tuberculosis Elimination Programme, India In order to reduce catastrophic expenditure for various schemes under the National Tuberculosis Elimination Programme, end-to-end digital processing of benefits to various beneficiaries was assessed for feasibility, using Nikshay, the national tuberculosis (TB) patient management system. This demonstrated near real-time communication of process status to all stakeholders, resulting in increased transparency, accountability and process efficiency.

Manu Easow Mathew

12:59 - 13:07: OA-26-664-23-Improving TB patients treatment adherence via electronic monitors and an app vs usual care in Tibet: a pragmatic randomised controlled trial We report the interim analysis of the randomised controlled trial in Tibet, China, that is using electronic monitoring boxes to improve patient adherence to anti-tuberculosis medications. We find e-applications becoming better accepted by healthcare workers and patients during the COVID-19 pandemic period.

Xiaolin Wei

13:07 - 13:15: OA-26-665-23-Preliminary results of a randomised trial comparing traditional in-person directly observed therapy and video-based observed therapy for monitoring TB treatment We conducted a randomised, two-period cross-over trial in New York City tuberculosis (TB) clinics to determine if video-based observed therapy (VOT) is non-inferior to in-person, directly observed therapy (DOT) for assuring adherence to TB treatment. The non-inferiority margin was 10%. We report primary results using intention-to-treat, per protocol, and empiric as-treated approaches.  

Joseph Burzynski

13:15 - 13:23: OA-26-666-23-Assessing adverse events among patients using in-person and electronic directly observed therapy In a randomised cross-over trial comparing in-person directly observed therapy (DOT) with electronic DOT for tuberculosis treatment in New York City, we analysed the reporting and severity of adverse events and the time taken to access care for each DOT method.

Marco M. Salerno

13:23 - 13:50: Q&A